Vanguard Group Inc Bio Affinity Technologies, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BIAF
# of Institutions
18Shares Held
512KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA119KShares$33,2320.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$15,0450.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$7,8070.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL22.5KShares$6,3000.05% of portfolio
-
Hrt Financial LP New York, NY18.8KShares$5,2750.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $764K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...